Abstract
Introduction
Coronary artery disease (CAD) is the common cause of death in developed countries and its prevalence is rising rapidly in developing countries (1) . Myocardial infarction (MI) is the most acute form of CAD (2) . CADs are classified as complex multifactorial disorders, which involved the contributions of many different genes, as well as environmental factors. A major current challenge is therefore to elucidate the genetic components that contribute to the pathogenesis of complex diseases (3) . Several recent studies accumulate data in favor of the Homocysteine metabolism down regulation as a risk factor for congenital heart diseases (CHDs), MI and stroke (4) (5) (6) . Homocysteine is a sulfur amino acid normally found in blood. Elevated homocysteine levels (also called hyperhomocysteinemia) may cause irritation of the blood vessels. Upper levels of homocysteine show an increased risk for hardening of the arteries (atherosclerosis), which could eventually result in a heart attack and/ or stroke, and blood clots in the vein, referred to as Venus thrombosis (3, 7) . Hyperhomocysteinemia can result from genetic factor like mutation in Methylenetetrahydrofolate reductase (MTHFR) gene or due to environmental factor like deficiency of B12 or folic acid (4) . MTHFR is a vitamin B12-dependent enzyme, plays a crucial role in remethylation of homocysteine to methionine by 5-methyltetrahydrofolate which coded by the gene on chromosome 1 (1p36.3). Any changes in MTHFR gene may disrupt this conserved regulation pathway, which lead to hyperhomocysteinemia (8, 9) . There are two common polymorphisms in the gene codes for the MTHFR enzyme, C677T and A1298C. The codon 677 polymorphism (rs1801133), in exon 4 of the gene, lies within the NH 2 -terminal catalytic domain, whereas the codon 1298 polymorphism is in the COOH-terminal regulatory region in exon 7 (3) . Individuals who have a C to T substitution at base 677 of the gene (amino acid change A222V) have reduced enzyme activity and higher homocysteine (3, 10, and 11). The second prevalent polymorphism A1298C (rs1801131) is also associated with decreased enzyme activity in vitro. This genetic variant consists of an A to C transversion at nucleotide 1298, which produces a Glu to Ala substitution (10) . Elucidation of an association, if any, between these polymorphisms and MI risk might be informative regarding the hypothesis that impaired folate metabolism, resulting in high homocysteine concentrations, plays a causal role in the occurrence of MI. The aim of the present study was to assess the prevalence of SNPs of MTHFR gene (C677T and A1298C) and its relation to MI by conducting a casecontrol study.
Materials and Methods

Subjects
A total 108 subjects, 54 patients (mean age 51.4 ± 13.5) with at least one experience of MI and 54 controls (mean age 51.6 ± 13.2) with no previous history of heart diseases were enrolled in this study from Marvdasht town in Fars province. Group matching of cases and controls was done for age and sex. All participants gave their informed consent prior to their inclusion in the study.
Molecular analysis
Genomic DNA was extracted from whole blood by standard phenol-chloroform salting out method. The quality of extracted gDNA was checked on 1.5% agarose gel. Genotypic analysis for both SNPs (C677 & A1298) were determined in DNA by PCR-RFLP assay. Two pair of primers was designed to amplify the flanking regions of codon 677 and 1298 in MTHFR gene which resulted in 198bp and 143bp amplicons respectively (Table 1) . PCR analysis of both 677 and 1298 gene polymorphisms were carried out in a total volume of 25 ml, containing genomic DNA (50ng); 1.5 mM MgCl 2 , 200 mM dNTP, 10 pmol/μl of each primer; 1x Taq polymerase buffer and 1 unit of Taq DNA Polymerase (Cinnagen, Iran). For C677T, the thermocycling procedure consists of initial denaturation at 94 ºC for 3 min, followed by 30 cycles of denaturation (94 ºC for 1 min), annealing (67 ºC for 1 min) and extension (72 ºC for 1 min), and final extension (72 ºC for 7 min). Amplification was achieved with a gradient BioRad t100 thermocycler (USA). Amplicons were resolved as a single band by 3% agarose gel electrophoresis prior to RFLP analysis to ensure that a specific single product was amplified. The PCR product was incubated with 1 unit of Hinf I (MBI Fermentas) at 37 ºC for 3 hours, using the buffer supplied by the manufacturer.
The digested product was separated on 3% agarose gel electrophoresis and photographed using Uvitec (Cambridge, UK) gel documentation system. After electrophoresis, the gel was stained with ethidium bromide. The sizes were determined using 100 bp ladder (Fermentas, Germany). The restriction site resulted from C to T transition, is located at the GTC codon encoding the amino acid valin forming a cuttable site. An uncuttable site at codon GCC encoding the amino acid alanin will remain intact (198 bp equal to wild type homozygous TT 
Results
The average age of the patients were 51.4 ± 13.5 (range from 24 to 81), as well as in control group with mean age 51. Post digestion documentation was done on gel and as shown in figures 3 and 4, TT, CC (for C677T) and AA, AC, CC (for A1298C) genotypes were seen ( Figure 3 and Figure 4 ). Detailed genotypic distributions for studied SNPs were summarized in Table 2 . Control subjects for the genotypic frequencies of A1298 polymorphism were in Hardy-Weinberg equilibrium (χ 2 = 4.8, df= 2, p= 5.99), but not for C677 (χ 2 = 41.34, df= 1, p= 3.84). Logistic regression analysis showed that there was no significant association between A1298C polymorphism and susceptibility to MI ( Table 2) . As statistical analyses on C677T showed, the polymorphic variants were more prevalent among patients, whereas the wild types were more commonly seen in controls. The frequencies of the CC and TT genotypes among control group were 70.4% and 29.6% respectively, whereas the corresponding frequencies in MI patient group were 16.7% and 83.3%, respectively. The homozygous polymorphic genotype TT showed statistically strong significant association with MI (OR= 11.87, 95% CI: 4.7-29.9, p < 0.001, Table 2 ). Nobody with CT genotype were found in both patient and control groups. Allele frequencies for C677T SNP among patients and controls were 0.17 and 0.7% for allele C (wild type), respectively and 0.83 and 0.3% for allele T (mutant), respectively ( For MTHFR C677T, the polymorphic homozygous TT was the most prevalent genotype found in study population (83.3%), followed by wild type homozygous (CC) (19.6%). Heterozygosity for C677T was not evaluated in both controls and patients. The T allele in the present study was found to be associated with higher MI risk (0.83 in patients vs. 0.30 in normal controls). The frequency of occurrence of the polymorphic allele has been shown to vary among different ethnic groups of the world (4, 12) . The result of our allelic frequency is in consistent with the previous research on the association of C677T with CAD in Iranian sample population (13) . In a report from Egyptian population, which included 40 cases and 25 controls, no significant association was shown between T allele and CAD (P>0.05) (14). Our study is also at variance with a study from Pandey et al (2011) , which found no significant association between T allele and CAD in Indian patients (C vs. MTHFR gene is involved in the remethylation of homocysteine to methionine. The activity of MTHFR enzyme is a crucial factor determining the level of homocysteine in plasma (9) . Two common polymorphisms reports for this gene. C677T exhibit a C to T transition at codon 222, which substitutes conserved Val with Ala. This replacement reduces the activity of the enzyme (16). A1298C results from an A to C transversion which decreased the enzyme activity measured in vitro (17) . Therefore, the polymorphisms may affect the homocysteine, endothelial toxin, which introduces as a risk factor for atherosclerotic disease including stroke and MI. Statistically significant correlation was found in our study between TT genotype and the risk of MI (OR= 11.87, 95% CI: 4.7-29.9, p<0.001). Our study is consistent with the hypothesis that C677T MTHFR polymorphism may be an important risk factor for the MI in a selected population (13 (20) . A meta-analysis of MTHFR C677T polymorphism and CAD found no strong evidence to support the association of this polymorphism with CAD in Europe, North America or Australia but in Asia (21) . This geographical variability may be attributed to higher folate intake in these countries. The results suggested that MTHFR C677T polymorphism is an informative genetic variant which can be used as a diagnostic marker for predisposed individuals to MI. The association between MTHFR C677T variant and CADs is obvious but, further studies are necessary to ascertain the relationship between the TT genotype of MTHFR 677 and homocysteine levels in plasma to clear the mechanism of its acting in increasing the risk of atherosclerosis.
